157 related articles for article (PubMed ID: 36037137)
1. Inferior Clinical Outcomes of Pediatric Rhabdomyosarcoma in Thailand: A 16-Year Experience in a Single Tertiary Institution.
Preechawetchakul P; Sripornsawan P; Rajborirug S; Sangkhathat S; Sangsupavanich P; Chotsampancharoen T
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2805-2811. PubMed ID: 36037137
[TBL] [Abstract][Full Text] [Related]
2. Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Harrison DJ; Qumseya A; Xue W; Arnold M; Lautz TB; Hiniker SM; Thomas SM; Venkatramani R; Weiss AR; Mascarenhas L
Pediatr Blood Cancer; 2024 Apr; 71(4):e30847. PubMed ID: 38282125
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
4. Clinical and pathological characteristics, treatment outcome and prognostic factors in adult rhabdomyosarcoma: a monocentric retrospective study.
Saadi M; Letaief F; Gabsi A; Mokrani A; Meddeb K; Mezlini A
Pan Afr Med J; 2022; 41():246. PubMed ID: 35734321
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic traits and prognostic factors associated with pediatric sinonasal rhabdomyosarcoma.
Siddiqui SH; Siddiqui E; Bavier RD; Patel NM; Kiliç S; Baredes S; Hsueh WD; Eloy JA
Int Forum Allergy Rhinol; 2019 Apr; 9(4):363-369. PubMed ID: 30629809
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological Characteristics, Survival Outcomes, and Prognostic Factors in Adult Patients With Sinonasal Rhabdomyosarcoma: Insights from a Retrospective Cohort Study.
Durzynska M; Dos Santos FLC; Michalek IM
Anticancer Res; 2023 Oct; 43(10):4517-4524. PubMed ID: 37772581
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Factors and Treatment Outcomes of Adult Patients With Rhabdomyosarcoma After Multimodality Treatment.
Liu YT; Wang CW; Hong RL; Kuo SH
Anticancer Res; 2019 Mar; 39(3):1355-1364. PubMed ID: 30842169
[TBL] [Abstract][Full Text] [Related]
8. A Web-Based Prognostic Model for Pediatric Genitourinary Rhabdomyosarcoma: Analysis of Population-Based Cohort With External Validation.
Li J; Huang Y; Li Y; Liu P; Cheng H; Song H; Sun N; Shamil MA; Zhang W
Front Public Health; 2022; 10():870187. PubMed ID: 35619827
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and outcomes of infants compared with children diagnosed with rhabdomyosarcoma: Analysis of surveillance, epidemiology and end results data from 2000 to 2016.
Rees HD; Hills NK; Sabnis AJ; Tulpule AB; Shimotake TK; Goldsby RE
Cancer Rep (Hoboken); 2022 May; 5(5):e1503. PubMed ID: 34254742
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group.
Rodeberg DA; Garcia-Henriquez N; Lyden ER; Davicioni E; Parham DM; Skapek SX; Hayes-Jordan AA; Donaldson SS; Brown KL; Triche TJ; Meyer WH; Hawkins DS
J Clin Oncol; 2011 Apr; 29(10):1304-11. PubMed ID: 21357792
[TBL] [Abstract][Full Text] [Related]
11. Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children.
Lim SM; Yoo CJ; Han JW; Cho YJ; Kim SH; Ahn JB; Rha SY; Shin SJ; Chung HC; Yang WI; Shin KH; Rho JK; Kim HS
Cancer Res Treat; 2015 Jan; 47(1):9-17. PubMed ID: 25143049
[TBL] [Abstract][Full Text] [Related]
12. Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Heske CM; Chi YY; Venkatramani R; Li M; Arnold MA; Dasgupta R; Hiniker SM; Hawkins DS; Mascarenhas L
Cancer; 2021 Mar; 127(6):946-956. PubMed ID: 33216382
[TBL] [Abstract][Full Text] [Related]
13. Adherence to Treatment, Response and Patterns of Failure in Pediatric Parameningeal Rhabdomyosarcoma: Experience From a Tertiary Cancer Care Center From India.
Roy S; Pathy S; Mohanti BK; Chander S; Biswas A
J Pediatr Hematol Oncol; 2017 Mar; 39(2):e62-e68. PubMed ID: 28060113
[TBL] [Abstract][Full Text] [Related]
14. Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.
Heerema-McKenney A; Wijnaendts LC; Pulliam JF; Lopez-Terrada D; McKenney JK; Zhu S; Montgomery K; Mitchell J; Marinelli RJ; Hart AA; van de Rijn M; Linn SC
Am J Surg Pathol; 2008 Oct; 32(10):1513-22. PubMed ID: 18708938
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study.
Vaarwerk B; van der Lee JH; Breunis WB; Orbach D; Chisholm JC; Cozic N; Jenney M; van Rijn RR; McHugh K; Gallego S; Glosli H; Devalck C; Gaze MN; Kelsey A; Bergeron C; Stevens MCG; Oberlin O; Minard-Colin V; Merks JHM
Cancer; 2018 Mar; 124(5):1016-1024. PubMed ID: 29211298
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in children with head and neck rhabdomyosarcoma: A 12-year retrospective study.
Zhang Y; Zhang WL; Huang DS; Wang YZ; Hu HM; Mei YY; Zhi T
Brain Behav; 2020 Aug; 10(8):e01697. PubMed ID: 32548972
[TBL] [Abstract][Full Text] [Related]
17. Treatment Outcomes and Prognostic Factors of Adult Sinonasal Sarcomas: A Single-Institution Case Series.
Ding J; Wang C; Xiang J; Shen C; Hu C; Xu T; Lu X
Med Sci Monit; 2018 Sep; 24():6113-6118. PubMed ID: 30173244
[TBL] [Abstract][Full Text] [Related]
18. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
[TBL] [Abstract][Full Text] [Related]
19. Pediatric rhabdomyosarcoma with bone marrow metastasis.
Bailey KA; Wexler LH
Pediatr Blood Cancer; 2020 May; 67(5):e28219. PubMed ID: 32100935
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997.
Blakely ML; Andrassy RJ; Raney RB; Anderson JR; Wiener ES; Rodeberg DA; Paidas CN; Lobe TE; Crist WM;
J Pediatr Surg; 2003 Mar; 38(3):347-53. PubMed ID: 12632347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
